Literature DB >> 16854071

Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization.

Ludovic Bannwarth1, Albane Kessler, Stéphanie Pèthe, Bruno Collinet, Naïma Merabet, Nicole Boggetto, Sames Sicsic, Michèle Reboud-Ravaux, Sandrine Ongeri.   

Abstract

We have designed, synthesized, and evaluated the inhibitory activity and metabolic stability of new peptidomimetic molecular tongs based on a naphthalene scaffold for inhibiting HIV-1 protease dimerization. Peptidomimetic motifs were inserted into one peptidic strand to make it resistant to proteolysis. The peptidic character of the molecular tongs can be decreased without changing the way they inhibit dimerization. Mutated HIV-1 proteases are also vulnerable to dimerization inhibitors, and the multimutated protease ANAM-11 is twice as sensitive to the inhibitor compared to wild-type protease. Thus, the metabolic stability of antidimeric molecular tongs can be increased without compromising their ability to inhibit wild-type and mutated HIV-1 proteases in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854071     DOI: 10.1021/jm060576k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme function.

Authors:  Jay Chauhan; Shen-En Chen; Katherine J Fenstermacher; Aurash Naser-Tavakolian; Tali Reingewertz; Rosene Salmo; Christian Lee; Emori Williams; Mithun Raje; Eric Sundberg; Jeffrey J DeStefano; Ernesto Freire; Steven Fletcher
Journal:  Bioorg Med Chem       Date:  2015-09-07       Impact factor: 3.641

Review 2.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

Authors:  Arun K Ghosh; Heather L Osswald; Gary Prato
Journal:  J Med Chem       Date:  2016-01-22       Impact factor: 7.446

3.  Atomistic simulations of the HIV-1 protease folding inhibition.

Authors:  Gennady Verkhivker; Guido Tiana; Carlo Camilloni; Davide Provasi; Ricardo A Broglia
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

4.  The energy landscape of a selective tumor-homing pentapeptide.

Authors:  David Zanuy; Alejandra Flores-Ortega; Jordi Casanovas; David Curcó; Ruth Nussinov; Carlos Alemán
Journal:  J Phys Chem B       Date:  2008-06-28       Impact factor: 2.991

5.  Current and Novel Inhibitors of HIV Protease.

Authors:  Jana Pokorná; Ladislav Machala; Pavlína Rezáčová; Jan Konvalinka
Journal:  Viruses       Date:  2009-12-11       Impact factor: 5.048

6.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

7.  HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Dominique Coulaud; Laurence Hameau; Sophie Lafosse; Josette Jeusset; Isabelle Borde; Michèle Reboud-Ravaux; Tobias Restle; Robert J Gorelick; Eric Le Cam
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

Review 8.  Development of peptide inhibitors of HIV transmission.

Authors:  Siyu Shi; Peter K Nguyen; Henry J Cabral; Ramon Diez-Barroso; Paul J Derry; Satoko M Kanahara; Vivek A Kumar
Journal:  Bioact Mater       Date:  2016-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.